Merck | MRK - الأصول





الأصول تغيير تاريخ
Adidas EUR 21.06B 610M 2026-06
Adyen EUR 14.72B 2.47B 2026-06
Akzo Nobel EUR 16.13B 647M 2026-06
Alcon AG USD 31.1B 521M 2026-06
Amadeus IT EUR 11.76B 332.2M 2026-06
Amarin USD 624.36M 21.4M 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
BASF EUR 83.87B 2.1B 2026-06
Bayer EUR 107.29B 659M 2026-06
Beiersdorf EUR 12.76B 166M 2025-12
Covestro EUR 13.47B 245M 2025-12
Danone EUR 48.62B 3.55B 2026-06
Fresenius EUR 41.84B 526M 2026-06
Fresenius Medical Care EUR 31.29B 174.35M 2026-06
Genmab DKK 12.52B 139M 2026-06
Givaudan CHF 11.86B 587M 2025-12
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
GRIFOLS EUR 20.09B 12M 2026-06
Henkel EUR 36.5B 3.96B 2026-06
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Infineon EUR 31.66B 54M 2026-06
Lakefront Biotherapeutics EUR 3.35B 21.24M 2026-06
Linde USD 86.32B 502M 2026-03
Lonza CHF 18.97B 164M 2025-12
Merck EUR 52.69B 383M 2026-06
Novartis USD 122.03B 3.5B 2026-06
Philips EUR 26.7B 565M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
UCB EUR 18.16B 971M 2025-12